Duke University Press
Qty. Item Name Cost
No Items Exist In Your Shopping Bag
  • Finding everything you need? See our Contact/FAQ if you have any questions.

We apologize for the inconvenience. Ordering is currently unavailable through our site. To order, please e-mail orders@dukeupress.edu or call us at 888-651-0122 (US) or 1-919-688-5134 (international) between 7:30 am and 5:30 pm EDT.

  • Acknowledgments  ix
    List of Illustrations  xi
    Introduction  1
    1. Responding to Facts  27
    2. Pharmaceutical Witnessing and Direct-to-Consumer Advertising  55
    3. Having to Grow Medicine  87
    4. Mass Health: Illness Is a Line You Cross  105
    5. Moving the Lines: Deciding on Thresholds  135
    6. Knowing Your Numbers: Pharmaceutical Lifestyles  181
    Conclusion. Living in a World of Surplus Health: Frequently Asked Questions  197
    Notes  219
    References  239
    Index  257
  • “Thought-provoking and chilling. . . . All registered nurses would . . . benefit from his analysis." — Lucia Hwang, National Nurse

    “What Drugs for Life does admirably well is to present a case for how a pharmaceutical approach to health became dominant – not by turning physicians or patients into dupes, but by filling them with conviction”. — Jill A. Fisher, Sociology of Health and Illness

    Reviews

  • “Thought-provoking and chilling. . . . All registered nurses would . . . benefit from his analysis." — Lucia Hwang, National Nurse

    “What Drugs for Life does admirably well is to present a case for how a pharmaceutical approach to health became dominant – not by turning physicians or patients into dupes, but by filling them with conviction”. — Jill A. Fisher, Sociology of Health and Illness

  • "Drugs for Life is simply superb, a major accomplishment in the study of pharmaceuticals and their expanding relation to life itself. There is no recent scholarly work that attempts or accomplishes what Joseph Dumit does here, tackling the relation between big pharma and clinical epistemology in such a comprehensive and satisfying way. He deftly links critical debates across the life and human sciences, making an important and compelling argument on a matter central to contemporary public debate."—Lawrence Cohen, author of No Aging in India: Alzheimer’s, the Bad Family, and Other Modern Things

    "Drugs for Life shocks the reader into seeing health, medicine, pharmaceuticals, and the pharmaceutical industry and drug research for what they are from a cultural standpoint: a new framing of the future world for all of us. And that future is now and troubling and transformative of human conditions. A remarkable contribution that will perturb and disturb professional and general readers."—Arthur Kleinman, coeditor of Global Pharmaceuticals: Ethics, Markets, Practices

    "In this provocative and important book, Joseph Dumit brings a new approach to bear on critiques of the pharmaceutical industry and U.S. healthcare. He marshals ethnographic research among drug company executives and marketing strategists, along with the analysis of scientific and popular representations of their products, showing how consumers have been tutored into a proactive stance toward health. Over the past few decades, we have come to live by 'the numbers' and 'risk factors' that make embracing lifelong pharmaceutical regimes seem like common sense. But is it? Dumit explores the pharmaceuticalization of American culture and consciousness with a light, accessible touch that belies the depth of his knowledge."—Rayna Rapp, author of Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America

    <
  • Permission to Photocopy (coursepacks)

    If you are requesting permission to photocopy material for classroom use, please contact the Copyright Clearance Center at copyright.com;

    If the Copyright Clearance Center cannot grant permission, you may request permission from our Copyrights & Permissions Manager (use Contact Information listed below).

    Permission to Reprint

    If you are requesting permission to reprint DUP material (journal or book selection) in another book or in any other format, contact our Copyrights & Permissions Manager (use Contact Information listed below).

    Images/Art

    Many images/art used in material copyrighted by Duke University Press are controlled, not by the Press, but by the owner of the image. Please check the credit line adjacent to the illustration, as well as the front and back matter of the book for a list of credits. You must obtain permission directly from the owner of the image. Occasionally, Duke University Press controls the rights to maps or other drawings. Please direct permission requests for these images to permissions@dukeupress.edu.
    For book covers to accompany reviews, please contact the bpublicity@dukeupress.edu.

    Subsidiary Rights/Foreign Translations

    If you're interested in a Duke University Press book for subsidiary rights/translations, please contact permissions@dukeupress.edu. Include the book title/author, rights sought, and estimated print run.

    Disability Requests

    Instructions for requesting an electronic text on behalf of a student with disabilities are available here.

    Rights & Permissions Contact Information

    Email: permissions@dukeupress.edu
    Email contact for coursepacks: asstpermissions@dukeupress.edu
    Fax: 919-688-4574
    Mail:
    Duke University Press
    Rights and Permissions
    905 W. Main Street
    Suite 18B
    Durham, NC 27701

    For all requests please include:
    1. Author's name. If book has an editor that is different from the article author, include editor's name also.
    2. Title of the journal article or book chapter and title of journal or title of book
    3. Page numbers (if excerpting, provide specifics)
    For coursepacks, please also note: The number of copies requested, the school and professor requesting
    For reprints and subsidiary rights, please also note: Your volume title, publication date, publisher, print run, page count, rights sought
  • Description

    Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs.

    About The Author(s)

    Joseph Dumit is Director of Science and Technology Studies and Professor of Anthropology at the University of California, Davis. He is the author of Picturing Personhood: Brain Scans and Biomedical Identity and editor, with Regula Valérie Burri, of Biomedicine as Culture: Instrumental Practices, Technoscientific Knowledge, and New Modes of Life.